Risk vs reward looks very compelling.
There will likely be a significant re-rate before interim results are released.
6M Market Cap for leverage into such a large clinical trial is rare.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.69M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $24.40K | 6.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 22260255 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 5451823 | 2 |
View Market Depth
| Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
| AVE (ASX) Chart |